The ERISA Industry Committee Urges Colorado to Reconsider New Mental Health Parity Rules

Washington, D.C., November 20, 2024 – The ERISA Industry Committee (“ERIC”) this week, submitted public comments on proposed regulations (Proposed Rules) from the Colorado Division of Insurance aimed at administering parity for mental health and substance use disorder benefits. ERIC’s public comments strongly urge Colorado regulators to reconsider the Proposed Rules, cautioning that if the state rules conflict with future changes to federal law, it could lead to future compliance conflicts and undermine how employers administer benefit plans.

ERIC President and CEO James Gelfand Named a Top Lobbyist of 2024

Washington, D.C., October 29, 2024 – The ERISA Industry Committee (ERIC) today announced that its president and CEO James Gelfand has been named one of the top 100 lobbyists in the U.S. by the National Institute for Lobbying & Ethics (NILE), an organization representing lobbying, public policy, and government affairs professionals. Gelfand and other 2024 recipients will be honored on November 7th during a reception in Washington, DC.

ERIC Applauds Governor Newsom’s Veto of Prescription Drug Bill that Violated Federal Law

Washington, D.C., October 2, 2024 – Today, The ERISA Industry Committee (ERIC) released the following statement on Governor Gavin Newsom’s (D-CA) veto of SB 966, a bill regulating pharmacy benefit managers (PBMs). While ERIC supports reform of PBMs, ERIC had previously cautioned lawmakers and Governor Newsom that the CA legislation could overstep state authority by directly impacting the design and administration of plans covered under the Employee Retirement Income Security Act (“ERISA”). The statement is attributable to Dillon Clair, Director of State Advocacy, ERIC.